Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial
The AUDIT questionnaire (Alcohol Use Disorders Identification Test) was given to determine if there was alcohol abuse
Researchers tracking tirzepatide weight loss timelines often reference these same comorbidity thresholds because they align with the clinical trial inclusion criteria
Cardoso, D., Barthlmy, I., Blot, S
ESWT reduces pain and inflammation, helps to realign and repair collagen fibers, promotes rehydration of synovial fluid and fascial tissues, and restores friction-free knee mechanics
doi: 10.1124/pr.115.010629 Muhammad T, Pastore SF, Good K, Yu WH, Vincent JB